EVALUATION OF FUNCTIONAL PARAMETERS OF THE ANTERIOR SURFACE OF THE EYE AND EYELIDS IN THE CASE OF PRIMARY OPEN-ANGLE GLAUCOMA
N.M. Veselovska1,2, O.G. Pyatiizbyantseva2, I.B. Zaporozhchenko1,2, Z.F. Veselovska1,2
- Kyiv Medical University, Ukraine
- Ophthalmology Clinic of Kyiv City Hospital No. 1, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz68.01.069
![](/images/cite.png)
Abstract
To conduct an analysis of the anterior surface of the eye in
patients with the newly diagnosed primary open-angle glaucoma in order to choose treatment with or without preservative.
We evaluated the front surface of the eye in 46 patients (92
eyes) diagnosed with primary open-angle glaucoma: 20 men
and 26 women aged from 58 to 80 years. The anterior surface
of the eye was examined using an analyzer of the anterior eye.
The signs of previously diagnosed dry eye syndrome (DES)
with various manifestations of dysfunction of meibomian
glands and complaints about dry eyes, foreign body sensation,
lacrymation and blurred vision were reported in 39 patients
(85%). Based on the examination results, preservative-free
topical hypotensive medications were recommended for these
39 patients. In order to preserve visual functions and quality
of life in patients with newly diagnosed POAG, it is advisable
to conduct a preliminary assessment of the condition of the
anterior surface of the eye when prescribing drug therapy
in order to rationalize the choice of first-line drugs with
or without preservative in accordance with the European
recommendations of Diagnosis and Treatment for glaucoma.
Keywords:
preservative-free medications; dry eye syndrome; primary open-angle glaucoma.
References
- Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334-65.
CrossRef
PubMed
- Şimşek C, Doğru M, Kojima T, Tsubota K. Current Management and Treatment of Dry Eye Disease. Turk J Ophthalmol. 2018;48(6):309-13.
CrossRef
PubMed PubMedCentral
- Brzheskiy VV, Egorova GB, Egorov EA. Dry eye syndrome and ocular surface disease: clinic, diagnostics, treatment. Moscow; 2016. [Russian].
- Brzheskii VV, Somov EE. Dry eye syndrome. Saint Petersburg;1998. [Russian].
- Golubev SYu, Kuroyedov AV. Choice of cost-effective medicine for the prevention and treatment of dry eye syndrome. Sindrom sukhogo glaza: Spets. izdanie Moskovskoy assotsiatsii oftalmologov. 2002:3:12-4. [Russian].
- Cvenkel B, Štunf Š, Srebotnik Kirbiš I, Strojan Fležar M. Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma. Clin Ophthalmol. 2015;9:625-31.
CrossRef
PubMed PubMedCentral
- Brzhevskiy VV, Somov EE. Dry eye syndrome in patients with inherited glaucoma. Russ J Clin Ophthalmol. 2003;4(3):139-41. [Russian].
- Boyko EV, Simakova IL, Yakushev DY, Ignat'ev SA, Alekseev IB, Mel'nikova NV, et al. Russ Ann Ophthalmol. 2015;131(3):22-6. [Russian].
CrossRef
PubMed
- Realini T, Barber L, Burton D. Frequency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma. Ophthalmology. 2002;109(7):1367-71.
CrossRef
- Varma R, Hwang LJ, Grunden JW, Bean GW. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials. Am J Ophthalmol. 2008;145(2):336-42.
CrossRef
PubMed
- Kuroedov AV. Primary open-angle glaucoma in different age groups. Glaucoma News. 2007;4:31. [Russian].
- Kurysheva NI, Parshunina OA, Ardzhevnishvili TD, Arakelyan RK, Lagutin MB. New diagnostic markers of glaucoma. Glaucoma News. 2015;1(33):131-3. [Russian].
- Baudouin C. Detrimental effect of preservatives in eyedrops: Implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86(7):716-26.
CrossRef
PubMed
- Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-7.
CrossRef
PubMed PubMedCentral
- Lemij HG, Hoevenaars JG, van der Windt C, Baudouin C. Patient satisfaction with glaucoma therapy: reality or myth? Clin Ophthalmol. 2015;9:785-93.
CrossRef
PubMed PubMedCentral
- Arici MK, Arici DS, Topalkara A, Güler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol. 2000;28(2):113-7.
CrossRef
PubMed
- Abysheva LD, Avdeev RV, Alexandrov AS, Arapiev MU, Bakunina NA, Baranova NA, et al. Influence of local hypotensive glaucoma therapy on the development and progression of dry eye syndrome. Russ J Clin Ophthalmol. 2017;17(2):74-82. [Russian].
Veselovskaya ZF, Veselovskaya NN. Zaporozhchenko IB. Preservative free tafluprost in the medical treatment of POAG in patients with type 2 diabetes mellitus. Egypt J Ophthalmol. ID: EJOMOS-2102-10-15
- Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol. 2008;246(11):1593-601.
CrossRef
PubMed
- Terminology and Guidelines for Glaucoma. 5th ed. Savona: PubliComm; 2020.
|